Cellectis filed an action for declaratory judgment against Precision Biosciences over a patent related to meganuclease variants for cleaving DNA. 9/30, District of Delaware, 1:2011cv00890.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.
